Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Continue reading
Category Archives: AZBio News
Cancer Moon Shot 2020
Historic National Coalition formed to accelerate next generation immunotherapy in cancer careContinue reading
ASU names LaBaer interim executive director of the Biodesign Institute
Dr. Joshua L. LaBaer, named interim executive director for the Biodesign Institute at Arizona State University.
TGen study targets SGEF protein in treating glioblastoma brain tumors
Study funded by Ivy Foundation shows SGEF plays roles in how cancer cells survive and invade brain tissueContinue reading
$190 M Licensing Deal Announced with Cancer Prevention Pharmaceuticals
SUCAMPO ENTERS INTO EXCLUSIVE OPTION AND COLLABORATION AGREEMENT WITH CANCER PREVENTION PHARMACEUTICALS FOR DEVELOPMENT OF LATE-STAGE CPP-1X/SULINDAC COMBINATION FOR FAMILIAL ADENOMATOUS POLYPOSIS
Spicy Arthritis Treatment Moves to Clinical Trials
A UA research team studying the anti-inflammatory impact of turmeric is moving the project out of the laboratory and into patient testing. (Source)Continue reading
In memoriam: Peter N. Allison (1950 – 2015)
Life science entrepreneur, investor,and philanthropist Peter N. Allison passed away unexpectedly in Scottsdale, AZ on December 22, 2015.Continue reading
CTCA at Western Regional Medical Center advances combination immunotherapy clinical trial
Lung Cancer Pioneers Create Lung Cancer Eradication Pact: VisionGate Acquires Exclusive Rights to University of Colorado’s Chemoprevention Drug Iloprost
Partnership Would Combine Company’s Patented Technology that Detects Pre-cancer of the Lungs with Drug Treatment that Prevents Cancer Continue reading
Making LIFE Better: Report documents TGen’s $174 million in total annual economic impact
TGen continues to grow as an economic engine for Arizona, creating high-paying jobs, state revenues and significant return on investment. Report documents TGen’s $174 million in total annual economic impact, while also attracting research dollars and advancing precision medicineContinue reading